SPY идет вверх на премаркете

Ближайший уровень поддержки по SPY – 193.50 уровень сопротивления – 195.00



NLNK выше 41 покупка, ниже продажа

IRB ниже 36,50 продажа

DUST смотрим на покупку

TLLP покупка выше 58

ASPS смотрим на откат вверх

Gapping up/down: NOK +9%, CAT +4% and GM +2% after earnings, BABA +1% after initiation at Overweight; YELP -12%, CAB -10%, CTXS -6% and UA -4% after earnings Price: null Change: null

Gapping up
In reaction to strong earnings/guidance: JAKK +16.2%, EGHT +13.4%, SCSS +13.3%, TSCO +12.6%, INFN +12.6%, DAN +9.8%, NOK +8.7%, ACTG +8.3%, LCI +7.3%, PLCM +6.2%, LOGI +5.7%, YNDX +5.2%, JNS +5.2%, MKTO +4.5%, DO +4.4%, CAT +4.4%, ORAN +4.2%, SLM +4%, ORLY +3.9%, MLNX +3.5%, SHLM +3.3%, (following late move lower), ALXN +3%, FTNT +2.9%, LUV +2.7%, MMM +2.2%, NXPI +2.1%, SFG +2%, CSH +2%, BBW +2%, UNP +1.9%, NOW +1.8%, GM +1.7%, DMRC +1.6%, AB +1.6%, JBLU +1.5%, SGMO +1.4%, ORRF +1.3%, CAM +1.2%, RTN +1.1%, CMCSA +1%, CHKP +0.9%


M&A news: BRP +21.3% (Brookfield Asset Mgmt proposes to acquire 30% of Brookfield Residential Properties (BRP) not currently owned for $23.00/share), WWAV +7.2% (WhiteWave Foods or Boulder Brands (BDBD) may be possible takeover targets, according to Bloomberg real M&A column), PETM +3.1% (has received takeover interest from KKR (KKR) and outer PE firms, according to reports)

Other news: CYTX +50% (received FDA approval to resume ATHENA trial enrollment), VIMC +8.4% (announces $29.2 million contract win in Chenzhou city of Hunan province), KNDI +5% (still checking), PH +4.5% (increases quarterly dividend 31 percent and authorizes the repurchase of up to 35 million shares), RGLS +3.3% (after doubling yesterday), ERIC +3% (in symp with NOK), GPRO +2.9% (still checking), ING +2.1% (in symp with CS), BBRY +2.1% (trading higher, may be on NOK earnings, but also a story that co is unlikely to be acquired by Lenovo (LNVGY), according to reports), CSH +2% (approved the spin-off of its E-Commerce Division, Enova International, Inc., into an independent and separate publicly traded company), STX +1.7% (raises targeted annual dividend), UBS +1.7% (in symp with CS), CPXX +1.7% (pricing of a $12.9 million public offering of common stock at $1.95/unit and warrants to purchase common stock at $3.58/whole share and will have a term of five years), TWTR +1.5% (presented at Mobile Developer conf yday), V +1.3% (declared a quarterly dividend in the aggregate amount of $0.48 per share, a 20% increase), TSLA +1.2% (to enter Australia market, accoridng to reports), KMX +1% (raises share repurchase authorization by $2 bln), LYG +0.8% (plans to eliminate 9000 jobs, according to reports)

Analyst comments: ALU +6% (upgraded to Hold from Underperform at Jefferies), LUX +2.3% (upgraded to Buy from Hold at Berenberg), DOW +2% (upgraded to Buy from Hold at Deutsche Bank), BABA +1.1% (initiated with an Overweight at Barclays), ABBV +1% (resumed with a Overweight at JP Morgan), GSK +0.9% (upgraded to Overweight from Equal Weight at Barclays)

Gapping down
In reaction to disappointing earnings/guidance: AIRM -24.3%, YELP -12.5%, CAB -9.6%, CLB -6.8%, CTXS -6.6%, IPCM -6.2%, AWH -4.7%, (light volume), CAKE -4.5%, VAR -4.3%, ACAT -4%, UA -4%, OTEX -3.9%, DNKN -3.8%, TER -2.2%, SUSQ -2.1%, UN -1.9%, GOL -1.7%, LRCX -1.5%, WFT -1.5%, CA -1.3%, T -1%, PCP -1%, CCE -0.8%

Other news: ADHD -14.1% ( released a presentation with updated clinical trial results of Metadoxine Extended Release for the treatment of ADHD), FREE -9.1% (filed for 17,500,000 shares common stock, offering by selling stockholder), PT -5.4% (still checking), NMFC -3.8% (commences offering of 5,000,000 shares of common stock), WYY -3.7% (prices public offering of 6,896,552 shares of common stock at $1.45/share), ZAZA -1% (following 40% move higher yesterday), ISNS -0.9% (following 30% move higher yesterday), SPEX -0.8% (provides litigation update)

Analyst comments: MDCO -1.5% (downgraded to Neutral from Buy at BofA/Merrill)

Оригинал статьи: gtstocks.com/analytics-23-10-2014.html